Join our Free Newsletter and unlock 50% off AltIndexFree newsletter + 50% offJoin free
$0 100%
Total revenue, Q3 '26 ().

Similar companies

Company Revenue
No data for previous quarter available yet.

Did Lifecore Biomedical Beat Earnings?

Lifecore Biomedical (LFCR) reported Q3 '26 revenue of $0, down 100.0% year-over-year.

AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — Lifecore Biomedical’s job postings, web traffic, and employee business outlook. See the full LFCR stock analysis or the earnings calendar for upcoming reports.

Lifecore Biomedical Quarterly Financial Trends ()

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Revenue33M35M36M31M—23M34M—
Gross margin34.0%28.0%38.4%25.0%—19.2%35.3%—
Operating margin-6.0%-25.7%14.6%-9.9%—-20.1%7.5%—
Net income-6.6M-15M-1.1M-10M—-15M-6.2M—
Net margin-20.2%-42.0%-3.1%-32.1%—-64.6%-18.0%—
EPS————————

Lifecore Biomedical Earnings Trend Analysis

Over the eight quarters from Q4 '24 to Q3 '26, Lifecore Biomedical’s quarterly revenue moved from $33M to $0.

When Is Lifecore Biomedical’s Next Earnings Date?

Lifecore Biomedical reports earnings on a quarterly schedule. Its most recent report covered Q3 '26. For the confirmed upcoming date — and every other company reporting soon — see the LFCR earnings calendar.

Frequently Asked Questions: Lifecore Biomedical Earnings

Lifecore Biomedical's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.

Lifecore Biomedical reported Q3 '26 revenue of $0, down 100.0% from the same quarter a year earlier.

Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the LFCR AI Score.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.